LPCN
$2.78
Lipocine
$.06
2.21%
LPCN
Earnings Whisper ®
N/A
3rd Quarter September 2019
Consensus:  ($0.23)
Revenue:  N/A
Wednesday
Nov 6
After the close
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when LPCN reports earnings?
Beat
Meet
Miss

Where is LPCN's stock price going from here?
Up
Flat
Down
Stock chart of LPCN
Analysts
Summary of analysts' recommendations for LPCN
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Peers
Regeneron PharmaceuticalsCelgeneInterCeptVertex PharmaceuticalsBioMarin PharmaceuticalEndo International plcMylanZoetisJohnson & JohnsonPerrigo